Biotech companies are expected to develop 2.6 million square feet of mostly build-to-suit office space in Boston’s Cambridge submarket this year. “We’re not seeing this level of activity in other industries,” said Tim Van Noord, capital markets analyst at Grubb & Ellis. “Many of these biotech firms are high-credit tenants. Financing is hard to come by....
Start your Real Estate Finance Intelligence service today for full access
Subscribe
Not ready to subscribe? Register today for a free trial.
Free Trial
May 15, 2012 - Samantha Rowan
Barry LePatner, founder of New York law firm LePatner & Associates, talks about why the construction industry needs to change the way it works.
May 07, 2012 - Samantha Rowan
Steven Marks, a managing director at Fitch Ratings, talks to REFI TV about the the divergence between performance of real estate investment trusts in 24-hour coastal markets, versus inland suburban markets.
May 04, 2012 - Samantha Rowan
Ronald Dickerman, president of New York-based investment manager Madison International Realty, believes many investors are afraid to act given concerns about the U.S. and global economic environment.